Add to ORKGGiven the impact of the coronavirus disease 2019 (COVID-19) on patients with psoriatic disease (PsD), a session was devoted at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 annual meeting to discussing the current understanding of the risk of severe COVID-19 in patients with PsD. The effects of PsD and its treatment on prevention and treatment of COVID-19 with vaccinations, antiviral drugs, and monoclonal antibodies were discussed. The session concluded with a presentation on the perspectives of patient research partners about their experiences with COVID-19
A core mission of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA...
Introduction. With the onset of the COVID-19 pandemic the dermatological manifestations of the infec...
© 2021 Taylor & Francis Group, LLC.Background: Immunosuppressive therapy has been a great concern du...
Given the impact of the coronavirus disease 2019 (COVID-19) on patients with psoriatic disease (PsD)...
The coronavirus disease 2019 (COVID-19; caused by SARS-CoV-2) pandemic has affected the healthcare s...
The COVID-19 pandemic has a negative impact on all aspects of human life and can lead to the exacerb...
The efficacy and safety of coronavirus disease 2019 (COVID-19) vaccination in patients with autoimmu...
The efficacy and safety of coronavirus disease 2019 (COVID-19) vaccination in patients with autoimmu...
Coronavirus disease (COVID-19) is a highly contagious respiratory infection caused by severe acute r...
The efficacy and safety of coronavirus disease 2019 (COVID-19) vaccination in patients with autoimmu...
The pandemic known as coronavirus disease-19 (COVID-19) has quickly spread worldwide, with a signifi...
Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, there has been an open debate o...
ObjectivesTo investigate factors associated with severe COVID-19 in people with psoriasis (PsO), pso...
The PSOBIOTEQ study protocol was approved by the “Comité d’Evaluation de l’Ethique des projets de Re...
Introduction. With the onset of the COVID-19 pandemic the dermatological manifestations of the infec...
A core mission of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA...
Introduction. With the onset of the COVID-19 pandemic the dermatological manifestations of the infec...
© 2021 Taylor & Francis Group, LLC.Background: Immunosuppressive therapy has been a great concern du...
Given the impact of the coronavirus disease 2019 (COVID-19) on patients with psoriatic disease (PsD)...
The coronavirus disease 2019 (COVID-19; caused by SARS-CoV-2) pandemic has affected the healthcare s...
The COVID-19 pandemic has a negative impact on all aspects of human life and can lead to the exacerb...
The efficacy and safety of coronavirus disease 2019 (COVID-19) vaccination in patients with autoimmu...
The efficacy and safety of coronavirus disease 2019 (COVID-19) vaccination in patients with autoimmu...
Coronavirus disease (COVID-19) is a highly contagious respiratory infection caused by severe acute r...
The efficacy and safety of coronavirus disease 2019 (COVID-19) vaccination in patients with autoimmu...
The pandemic known as coronavirus disease-19 (COVID-19) has quickly spread worldwide, with a signifi...
Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, there has been an open debate o...
ObjectivesTo investigate factors associated with severe COVID-19 in people with psoriasis (PsO), pso...
The PSOBIOTEQ study protocol was approved by the “Comité d’Evaluation de l’Ethique des projets de Re...
Introduction. With the onset of the COVID-19 pandemic the dermatological manifestations of the infec...
A core mission of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA...
Introduction. With the onset of the COVID-19 pandemic the dermatological manifestations of the infec...
© 2021 Taylor & Francis Group, LLC.Background: Immunosuppressive therapy has been a great concern du...